Current Setup & Catalysts
Current Setup & Catalysts
1. Current Setup in One Page
The stock is trading at ₹32 — seven percent above its all-time low ₹30.30 and within five trading days of the FY26 audited result that the market is now still digesting. The recent setup is bearish-quiet: in the 3-6 months leading into today, the market learned that Onyx swung from a ₹4.95 Cr profit (FY25) to a ₹0.21 Cr loss (FY26) on revenue that grew 12% — and that management filed the result without an MD&A, without a concall, and without a forward statement. There is one hard-dated decision-event in the next six months — the H1FY27 result, due by ~14 November 2026 — and one structural soft-event window (the FY26 AGM and annual report by 30 September 2026). Every other watch-item is continuous (debtor days, Unit I LVP shipment, Akums-as-customer signals). The H1FY27 OPM print is the single number that updates the entire 5-to-10-year thesis; until then, the calendar is thin and the tape is mostly noise.
Recent Setup Rating: Bearish
Hard-Dated Events (Next 6M)
High-Impact Catalysts
Next Hard Date (days)
Price (₹, 20-May-2026)
vs ₹61 IPO (%)
52w Position (0=low)
FY26 OPM (%)
H2FY26 OPM (%)
The single highest-impact near-term event is the H1FY27 result print, due by ~14 November 2026 (Reg 33 / SME half-yearly cadence — 178 days away). That filing carries the H1FY27 operating margin number that every other specialist tab — business, financials, bull, bear, moat, long-term thesis — names as the decisive update to the entire investment debate. There is no second event in the next six months that competes for importance.
2. What Changed in the Last 3-6 Months
The window from late February to today is short but dense with information that re-priced the stock. The dominant event is the FY26 audited result on 14 May 2026, but the recent setup is also defined by what management did not do (no commentary, no concall, no buyback at sub-book) and by the post-anchor-lock-in distribution that has rolled into the tape.
The recent narrative arc is simple and unflattering. Before the FY26 print, the question investors were asking was "is FY26 a ramp year that absorbs the Unit II cost stack?". After 14 May 2026, the question changed to "is FY26 the new normal, and does H2's 7.02% OPM bounce on flat half-on-half revenue mean fixed costs are now in the run-rate?". The unresolved question — the one that drives the next six months — is whether the H2FY26 sequential improvement was the first half of a margin-recovery curve or the half-cycle ceiling of a price-taker that lost pricing power and is not getting it back. Nothing the company has said in 2026 helps the reader answer that.
3. What the Market Is Watching Now
The market is watching exactly four things, and none of them is what management is talking about (because management is not talking).
The H1FY27 OPM print sits at the top because it is the only variable that resolves the central FY26 question in a single observable number on a specific filing date. Everything else is either (a) a continuous signal that updates incrementally between half-yearly results, or (b) dependent on the OPM print landing first.
4. Ranked Catalyst Timeline
The ranking below is by decision value to an institutional investor, not by chronology. The H1FY27 result is ranked #1 because every other catalyst either feeds into it, follows from it, or matters less than it.
Calendar is thin and centred on one event. Outside the H1FY27 print and the FY26 AGM/annual report, there are no scheduled disclosure obligations capable of changing the underwriting debate. WHO-GMP renewal at Unit II falls on a 3-year cadence (next ~May 2027 — beyond the window). NSE Main Board migration eligibility is reached after 3 years post-listing (~Nov 2027) but the FY26 loss resets the sustained-profitability requirement. There are no investor days, no concalls, no guidance windows on a confirmed schedule.
5. Impact Matrix
This matrix isolates the catalysts that actually resolve the long-term debate, not the ones that merely add information. Four items qualify; one is rated 'mostly noise' because it does not update the durable thesis.
The matrix above makes the point that should drive coverage decisions: only two catalysts (H1FY27 OPM, Unit I LVP first shipment) actually move the 5-to-10-year thesis enough to force a re-underwrite. The FY26 AGM is a credibility test on a thesis variable (governance) that the market already discounts. The Akums signal is severe but slow-moving. Everything else either feeds into one of the four named above or is implementation friction without thesis content.
6. Next 90 Days
The next 90 days (today through ~19 August 2026) is a quiet window by design. No statutorily required filing falls into it; the FY26 audited result is already filed; the AGM/AR deadline is 30 September; the H1FY27 result is 14 November. Three things are still worth tracking in the window even though none is dated.
No meaningful hard-dated catalysts inside the next 90 days. The first hard date is the FY26 AGM / annual report deadline on 30 September 2026 (133 days from today, just outside this window's 90-day cut-off). The first decisive event is the H1FY27 result by ~14 November 2026 (178 days). A PM watching this name through August should treat the calendar as quiet and the technical line at ₹30-₹38 as the operative bracket.
7. What Would Change the View
The two or three observable signals that would force a thesis update in the next six months are narrow and concrete. First, the H1FY27 operating margin print on or before 14 November 2026 — at 12%+ with debtor days falling below 120 and CFO positive, the bear case to ₹16 dissolves and the operating-leverage frame becomes investable; at 7% or below with DSO above 150 and CFO negative, the long-term-thesis driver #1 (Unit II utilisation absorbs cost stack) is falsified and book value stops being a defensible floor. Second, the FY26 annual report by 30 September 2026 — a credible MD&A naming the specific cost lines that broke FY26 and offering a Unit II throughput disclosure would narrow the governance discount that is the largest non-operational drag on the multiple. Third, the Unit I LVP first-shipment disclosure at any point in the window — that single event resolves the IPO use-of-proceeds credibility question and unlocks the higher-margin product-mix lever in the prospectus story. The Akums-as-customer signal sits behind these three because it is slower-moving and arrives through Akums' own filings rather than Onyx's. Everything else on the page — the tape, the FII outflow, the promoter inactivity at sub-book — is implementation friction and credibility colour, not thesis content.